{"Title": "Cytoreductive nephrectomy in metastatic renal cancer \u2014 less is more", "Year": 2018, "Source": "Nat. Rev. Clin. Oncol.", "Volume": "15", "Issue": 10, "Art.No": null, "PageStart": 595, "PageEnd": 596, "CitedBy": 2, "DOI": "10.1038/s41571-018-0065-4", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049505285&origin=inward", "Abstract": "\u00a9 2018, Macmillan Publishers Ltd., part of Springer Nature.CARMENA, a trial comparing the efficacy of sunitinib alone to that of nephrectomy followed by sunitinib in patients with primary metastatic renal cell carcinoma who require targeted therapy has demonstrated the non-inferiority of systemic therapy alone. The data provided by this and other studies argue for a lesser role of surgery in the management of these patients.", "AuthorKeywords": null, "IndexKeywords": ["Carcinoma, Renal Cell", "Cytoreduction Surgical Procedures", "Humans", "Kidney Neoplasms", "Nephrectomy", "Sunitinib"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-85049505285", "SubjectAreas": [["Oncology", "MEDI", "2730"]], "AuthorData": {"7004237921": {"Name": "Bex A.", "AuthorID": "7004237921", "AffiliationID": "60015205", "AffiliationName": "Department of Urology, Netherlands Cancer Institute"}, "7003526080": {"Name": "Haanen J.", "AuthorID": "7003526080", "AffiliationID": "60015205", "AffiliationName": "Department of Immunology and Medical Oncology, Netherlands Cancer Institute"}}}